Issue link: https://www.e-digitaleditions.com/i/1045838
22 November 2018 Tablets & Capsules Elemental impurities limits. John A. McCarty. Eye on Excip- ients, May 2012, p. 33. Embracing QbD and PAT in nutraceutical production. Misty Muscarella, Charles Preuss, Y.V. Pathak, and Adnan Sabir. October 2011, p. 18. Everyone needs a war room. Carol Brennon. Back Page, October 2008, p. 96. Excipient GMP standards. Jim Morris. Eye on Excipients, October 2018, p. 43. Excipient quality and QbD. Alen Guy. Eye on Excipients, January 2012, p. 39. Excipient selection: Practical advice on using SUPAC. Metin Çelik. July 2008, p. 15. Excipients in the news. Matthew Knopp. Back Page, July 2013, p. 48. FDA draft Guidance on new dietary ingredients: Do you need to file? Amy Scanlin. July 2017, p. 32B. FDA hones guidance on PCIDs. Peter M. O. Wong. Back Page, April 2012, p. 56. FDASIA's effect on excipients. Bretta Lichtenhan, Dale Car- ter, Megan Bevill, Katherine Ulman, and Julie Budnick. Eye on Excipients, October 2013, p. 39. GMP compliance: The top seven pitfalls. Greta Houlahan. January 2012, p. 32B. Have a plan before the FDA arrives. Bryan J. Coleman. Back Page, October 2016, p. 52. Hospital unit-dose blisters: New format comes with new challenges. Bob Hartwig. May 2013, p. 8. How to ensure your dust collection system complies with combustible-dust standards. David Steil, Tony Supine, and Mike Walters. May 2013, p. 20. IPEC regulatory affairs conference 2007. John A. McCarty. Eye on Excipients, January 2008, p. 52. IPEC regulatory affairs conference 2008. John A. McCarty. Eye on Excipients, October 2008, p. 61. IPEC regulatory affairs conference 2009. John A. McCarty. Eye on Excipients, January 2010, p. 31. Implementing cleaning validation requires process under- standing. Parveen Bhandola. October 2012, p. 8. Incorporating comprehensive serialization in the pharma- ceutical industry. Andrew Pietrangelo. October 2016, p. 23. In-place cleaning and washing: Determining the need CIP and WIP systems for tablet presses. Stefania Barzanti, Cater- ina Funaro, Fabriano Ferrini, and Marcus Behrens. Septem- ber 2010, p. 8. Ingredient identity testing: The road to GMP compliance. Mara Whitten. April 2011, p. 32C. Is tablet coating ready for QbD? Michael Choi. Back Page, April 2009, p. 48. Management responsibility for a serialization and aggrega- tion system. Marcus Pabsch. March 2014, p. 33. Measuring bulk density: Advantages of a shear cell. Vinnie Hebert. October 2013, p. 31. Measuring water activity as a means to reduce microbial limit testing. Anthony J. Fontana. October 2008, p. 28. Quality assurance How to boost ingredient quality and promote its value to customers. Shaheen Majeed and Todd Pauli. July 2016, p. 32C. Raising the bar for quality. Chris Coker and Brian Garrett. Back Page, October 2018, p. 48. Regulation, standards, and guidance ANSI/ASHRAE Standard 199: A new tool for specifying pharmaceutical dust collection equipment. Rick Kreczmer and David Steil. March 2017, p. 35. Accounting for differences in TSM and EU tooling. Rich Kirk. July 2010, p. 34. Assessing an analytical method for the dissolution profile of an extended-release tablet in accordance with QbD. Maria Maeso Puertollano, Tim Cartwright, Mike Aylott, and Nicola Kaye. January 2009, p. 30. Assessing risk and controlling exposure to potent com- pounds during pharmaceutical packaging. John P. Farris. May 2010, p. 8. Blister technology adapts to meet regulatory and market demands. Matthew Knopp. May 2012, p. 14. The buck stops where? Clarifying responsibility under qual- ity agreements. Justin Prochnow. October 2015, p. 32B. Chitosan as a pharmaceutical excipient? John McCarty. Eye on Excipients, September 2013, p. 51. Clearing the regulatory hurdles to bring a supplement prod- uct to market. Justin J. Prochnow. July 2010, p. 32C. Combine the TSM and ISO tooling standards. Dale Natoli. Back Page, October 2010, p. 64. Compactability testing of excipients, part 1. Metin Çelik. Eye on Excipients, April 2009, p. 42. Compactability testing of excipients, part 2. Metin Çelik. Eye on Excipients, May 2009, p. 33. Compliance challenges facing the nutraceutical and dietary-supplement industries. Joy A. Joseph. March 2009, p. 32C. Containment of high-potency drug products: Outsourcing and other challenges. Emily Nystrom. March 2010, p. 8. Contracting with the dietary supplement cGMPs in mind. Paul M. Hyman and Bryon F. Powell. September 2009, p. 32C. Creating compliant labels for dietary supplements in Can- ada. Peter Wojewnik. September 2010, p. 32C. Differences Down-Under: Australian labels for complemen- tary medicines vs. US labels for dietary supplements. Robert Forbes. September 2010, p. 32D. Dispelling solid dosage misinterpretations of the USP-NF. Susan J. Schniepp. October 2009, p. 14. Drug product recalls: An overview of the process. Edward J. Bauer. May 2012, p. 8. Effect of sampling methods on vitamin D blending unifor- mity. Wenming Zeng, Dan Wang, and Doug Roper. Octo- ber 2016, p. 17. Elemental impurities. John McCarty. Eye on Excipients, March 2013, p. 39.

